Cerottini Jc
About
In The Last Decade
Cerottini Jc
19 papers receiving 371 citations
Peers
Comparison fields: 5 of 67
- Immunology 378
- Molecular Biology 86
- Radiology, Nuclear Medicine and Imaging 85
- Oncology 61
- Epidemiology 33
Countries citing papers authored by Cerottini Jc
This map shows the geographic impact of Cerottini Jc's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cerottini Jc with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cerottini Jc more than expected).
Fields of papers citing papers by Cerottini Jc
This network shows the impact of papers produced by Cerottini Jc. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cerottini Jc. The network helps show where Cerottini Jc may publish in the future.
Co-authorship network of co-authors of Cerottini Jc
This figure shows the co-authorship network connecting the top 25 collaborators of Cerottini Jc. A scholar is included among the top collaborators of Cerottini Jc based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cerottini Jc. Cerottini Jc is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | Human tumor immunotherapy. New opportunities as well as new challenges. | 2 |
| 2 | Limiting dilution analysis of alloantigen-reactive T lymphocytes. VI. Ontogeny of cytolytic T lymphocyte precursors in the thymus. | 15 |
| 3 | Limiting dilution analysis of alloantigen-reactive T lymphocytes. II. Effect of cortisone and cyclophosphamide on cytolytic T lymphocyte precursor frequencies in the thymus. | 44 |
| 4 | Human natural killer cells. | 7 |
| 5 | Inhibition of T cell-mediated cytolysis by 2-deoxy-D-glucose (2-DG): differential effect of 2-DG on effector cells isolated early or late after alloantigenic stimulation in vitro. | 17 |
| 6 | Generation of cytolytic T lymphocytes in vitro. X. Induction of primary and secondary CTL responses by the mitogen sodium periodate. | 7 |
| 7 | Analysis of human lymphocyte subpopulations responsible for antibody-dependent and spontaneous cell-mediated cytotoxicity. | 3 |
| 8 | Generation of cytolytic T lymphocytes in vitro. IX. induction of secondary CTL responses in primary long-term MLC by supernatants from secondary MLC. | 156 |
| 9 | Inhibition of cytolytic T lymphocyte activity with subcellular alloantigen preparations and with unlabeled allogeneic target cells. | 13 |
| 10 | Generation of Cytotoxic T Lymphocytes in Vitro VII. Suppressive Effect of Irradiated MLC Cells on CTL Response | 71 |
| 11 | Generation of cytolytic t lymphocytes in vitro from alloimmune spleen cells. | 1 |
| 12 | Generation of cytotoxic T lymphocytes in vitro. V. Response of normal and immune spleen cells to subcellular alloantigens. | 74 |
| 13 | [Use of immunologic tests in cancerology]. | 1 |
| 14 | In vivo studies of the role of cytotoxic T cells in tumor allograft immunity. | 46 |
| 15 | [Cytotoxic lymphocytes and anti-tumor immunity]. | 1 |
| 16 | [The carcinoembryonic antigen of the human digestive tract., Its importance in the diagnosis of certain cancers]. | 1 |
| 17 | In vivo activity of cytotoxic lymphocytes. | 3 |
| 18 | [Structure and biological activity of antibodies]. | 1 |
| 19 | Preparation and use of specifically purified antibodies for immunofluorescent labeling. | 8 |
| 20 | [Studies of the possibilities of the use of serum albumin as a transporter of antitumoral agents]. | 1 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.